37results about How to "Lower liver index" patented technology

The invention belongs to the technical field of traditional Chinese medicines and particularly relates to a traditional Chinese medicine composition and an application of the traditional Chinese medicine composition as a medicine for treating fatty liver. The traditional Chinese medicine composition for treating or preventing fatty liver comprises the following components in parts by weight: 5-15 parts of radix curcumae, 3-9 parts of poria cocos, 5-15 parts of pericarpium citri reticulatae, 5-15 parts of ligusticum wallichii, 18-23 parts of pinellia ternate, 18-23 parts of hawthorn, 5-15 parts of radix bupleuri, 15 parts of turmeric, 20-50 parts of semen cassiae, 2-7 parts of radix paeoniae alba, 3-9 parts of salviae miltiorrhizae and 5-15 parts of polygonum cuspidatum. The traditional Chinese medicine composition has a good curative effect on treatment of fatty liver and has a remarkable clinical application value.

The invention belongs to the technical field of medicine, and relates to a Chinese medicinal composition, in particular to a Chinese medicinal composition for treating chronic alcoholic toxic liver disease and a preparation method thereof. Aiming at the current technological defects that the chronic alcoholic toxic liver disease cannot be treated comprehensively and effectively and chemical treatment has the defects of high relapse rate and discontinuous curative effect, the Chinese medicinal composition for treating or preventing the chronic alcoholic liver toxic disease comprises the following components in parts by weight: 10 parts of corydalis tuber, 15 parts of fourstamen stephania root, 6 parts of virgate wormwood herb, 10 parts of glossy privet fruit, 10 parts of Szechuan lovage rhizome, 6 parts of Chinese angelica, 20 parts of sophora flower, 20 parts of tribulus terrestris, 10 parts of Chinese thorowax root, 12 parts of baikal skullcap root, 15 parts of baikal skullcap root, 30 parts of cassia twig, 6 parts of Indian buead and 10 parts of liquoric root. The Chinese medicinal composition has a very good treatment effect on the chronic alcoholic toxic liver disease, and has a remarkable clinical popularization value.

The invention discloses a preparation method and an application of pu-erh tea extractive with a blood fat reducing function. The preparation method comprises the following steps in sequence of: adding water to the pu-erh tea to leach; filtering the extracting liquid; absorbing by macroporous resin; eluting by ethanol-water solution; concentrating the leaching liquid until reaching a certain proportion; and drying the concentrate, thus obtaining the pu-erh tea extractive. According to the preparation method, the characteristic of high effective component content of the pu-erh tea extractive is utilized to prepare the tea drinks, tea bags, pu-erh cream and tea beverage which have the effects of obviously controlling the raise of the weight, reducing the liver index, fat index and LEE'S index, raising high-density lipoprotein cholesterol and reducing triglyceride.

The invention provides a medicine for preventing stoke. The medicine is prepared from the following raw materials in parts by weight: 10-20 parts of earthworm, 5-10 parts of Chinese angelica, 15-25 parts of root of kudzu vine, 4-10 parts of root of common peony, 3-8 parts of muscardine cadaver, 5-15 parts of ginseng, 10-15 parts of red flower, 8-15 parts of caulis spatholobi, 10-15 parts of centipede, 10-20 parts of pseudo-ginseng and 4-8 parts of radix polygonati officinalis. The medicine has the effect of preventing stroke and can be used for lowering morbidity of the stroke.

The invention provides rheum officinale oral liquid capable of protecting the liver and benefiting the gallbladder. The oral liquid is prepared from, by weight, 10-50 parts of rheum officinale, 10-20 parts of herba artemisiae capillariae, 10-20 parts of poria cocos, 10-20 parts of herba houttuyniae, 10-20 parts of radix bupleuri, 10-20 parts of radix paeoniae alba, 10-20 parts of angelica sinensis, 10-20 parts of corn stigma, 10-20 parts of herba cirsii, 10-20 parts of rhizoma polygoni cuspidati, 10-20 parts of wolfberries, 10-20 parts of glossy privet fruits, 10-20 parts of semen boitae, 10-20 parts of Chinese wax gourd peel, 10-20 parts of radix trichosanthis, 10-20 parts of curcuma zedoary, 10-20 parts of herba ecliptae, 10-20 parts of radix polygoni multiflori preparata, 10-20 parts of semen plantaginis, 10-20 parts of endothelium corneum gigeriae galli, 10-20 parts of rehmannia roots and 10-20 parts of isatis roots. According to the rheum officinale oral liquid capable of protecting the liver and benefiting the gallbladder and a preparation method thereof, due to the fact that the extraction technique of the traditional Chinese medicine is greatly improved, the toxic ingredients in the traditional Chinese medicine is reduced to the minimum to be capable of being absorbed by a human body, and the utilization rate of the traditional Chinese medicine is greatly improved.

The invention belongs to the technical field of medicine, and relates to a Chinese medicinal composition, in particular to a Chinese medicinal composition for treating chronic alcoholic toxic liver disease and a preparation method thereof. Aiming at the current technological defects that the chronic alcoholic toxic liver disease cannot be treated comprehensively and effectively and chemical treatment has the defects of high relapse rate and discontinuous curative effect, the Chinese medicinal composition for treating or preventing the chronic alcoholic liver toxic disease comprises the following components in parts by weight: 10 parts of corydalis tuber, 15 parts of fourstamen stephania root, 6 parts of virgate wormwood herb, 10 parts of glossy privet fruit, 10 parts of Szechuan lovage rhizome, 6 parts of Chinese angelica, 20 parts of sophora flower, 20 parts of tribulus terrestris, 10 parts of Chinese thorowax root, 12 parts of baikal skullcap root, 15 parts of baikal skullcap root, 30 parts of cassia twig, 6 parts of Indian buead and 10 parts of liquoric root. The Chinese medicinal composition has a very good treatment effect on the chronic alcoholic toxic liver disease, and has a remarkable clinical popularization value.

The invention belongs to the technical field of medicine, relates to a traditional Chinese medicine composition, and in particular relates to a traditional Chinese medicine composition for treating chronic alcoholic toxic liver disease and a preparation method thereof. Aiming at the current technical defects of lack of comprehensive and effective treatment on the chronic alcoholic toxic liver disease, easiness in relapse of chemical treatment, and inconstant curative effect, the invention provides the traditional Chinese medicine composition for treating chronic alcoholic toxic liver disease. The traditional Chinese medicine composition comprises the following components: 10 parts of rhizoma alismatis, 15 parts of Fourstamen Stephania root, 6 parts of herba artemisiae, 10 parts of fleece-flower root, 10 parts of rhizoma ligustici wallichii, 6 parts of angelica, 20 parts of hovenia dulcis, 20 parts of Chinese gall, 10 parts of radix bupleuri, 12 parts of rhizoma polygonati, 15 parts of Scutellaria baicalensis, 30 parts of Lycium barbarum L., 6 parts of Poria cocos, and 10 parts of liquorice. The traditional Chinese medicine composition has a very good treatment effect in the treatment of chronic alcoholic toxic liver disease, and has significant clinical promotion value.

The invention discloses application of short-chain fatty acid in prevention or / and treatment of liver injury. The short-chain fatty acid is a product of intestinal flora glycolysis dietary fibers, belongs to an endogenous substance, is small in toxic and side effects, simple in structure, easy to metabolize, convenient to obtain and low in price, and can improve liver functions, inhibit liver fatty degeneration, maintain intestinal health and prevent or / and treat liver injury.

The invention discloses a traditional Chinese medicine composition for treating fatty liver and relates to the technical field of traditional Chinese medicine. The traditional Chinese medicine composition is prepared by raw materials in parts by weight: 10 parts of rhizoma alismatis, 6 parts of capillary artemisia, 10 parts of panax pseudoginseng, 10 parts of ligusticum wallichii, 20 parts of fructus aurantii immaturus, 20 parts of hawthorn, 10 parts of bupleurum, 15 parts of scutellaria baicalensis, 30 parts of rhizoma atractylodis, 5 parts of root of herbaceous peony, 6 parts of salvia miltiorrhiza and 10 parts of liquorice. The traditional Chinese medicine composition has very good treatment effect in the treatment of fatty liver and significant clinical generalization value.

The invention belongs to the field of biological medicine, and relates to a histidine dipeptide composition for repairing liver injury, the histidine dipeptide composition comprises the following effective components: carnosine, goose carnosine, corbicula fluminea extract, radix puerariae extract and radix astragali extract, and the mass ratio of the carnosine to the goose carnosine to the corbicula fluminea extract to the radix puerariae extract to the radix astragali extract in the composition is (50-60): (20-25): (5-10): (5-10): (5-10). The histidine dipeptide composition provided by the invention can effectively prevent and / or treat liver injury in a certain proportioning range, especially has excellent effects in repairing liver cell injury, preventing and / or treating liver injury caused by hypeluricemia and treating clinical liver cell injury type liver diseases, and has the advantages of cheap raw materials, simple preparation method, low cost, and no toxic effect.

The invention belongs to the field of traditional Chinese medicine, and relates to the preparation of homogeneous polysaccharide in water extract of pueraria root and its lipid-lowering activity. The present invention separates the homogeneous polysaccharide QL from Jiangxi Daodi medicinal material—— Pueraria lobata. The in vivo experiment proves that the homogeneous polysaccharide of Pueraria lobata has significant lipid-lowering activity, significantly reduces the content of serum triglyceride and liver index, and can be used to develop potential safe and effective drugs. Lipid-lowering drugs.

The invention relates to an application of atractylenolide III in preparation of a medicine for treating a non-alcoholic fatty liver disease. It is found that atractylenolide III can reduce liver lipid deposition, reduce liver indexes, significantly reduce serum blood fat levels and liver tissue TG and TC levels and activate related signal molecules of an AMPK / SIRT1 signal channel; the MDA level can be reduced, the SOD and GSH-Px levels are increased, and the oxidative stress is improved. The atractylenolide III can inhibit lipid deposition by activating an AMPK / SIRT1 signal channel, reduce the oxidative stress reaction of liver cells, improve the expression level of CPT1A and improve the oxidative stress of mitochondria at the same time, and play a role in treating the non-alcoholic fatty liver disease through the mechanism. The atractylenolide III is a plant-derived chemical substance, the preparation steps are simple, the environmental pollution is small, and the method is suitable for industrial production. Therefore, atractylenolide III can be used for preparing the medicine or health food for treating the non-alcoholic fatty liver disease.

The invention discloses a Chinese herba preparation for regulating lipid and reducing weight, made by sticktight, hawthorn, roxburghrose, medlar and salvia miltiorrhiza. The medicines are combined to achieve synergistic effect of efficacies of all medicines, thus effectively removing stasis and activating blood, helping digestion, nourishing liver and kidney and replenishing qi to invigorate the spleen. Most medicines in the invention are food and have definite curative effect, thus being applicable to application for a long time, and price is low, thus being easy to develop and apply.